Trimethoprim R plasmids isolated during long-term treatment of urinary tract infection with co-trimoxazole.
作者信息
Towner K J, Pearson N J, Cattell W R, O'Grady F
出版信息
J Antimicrob Chemother. 1979 Jan;5(1):45-52. doi: 10.1093/jac/5.1.45.
PMID:762006
Abstract
摘要
相似文献
1
Trimethoprim R plasmids isolated during long-term treatment of urinary tract infection with co-trimoxazole.在长期使用复方新诺明治疗尿路感染期间分离出的甲氧苄啶R质粒。
J Antimicrob Chemother. 1979 Jan;5(1):45-52. doi: 10.1093/jac/5.1.45.
2
Failure to demonstrate an advantage in combining sulphamethoxazole with trimethoprim in an experimental model of urinary infection.在尿路感染实验模型中未能证明磺胺甲恶唑与甲氧苄啶联合使用具有优势。
J Clin Pathol. 1974 Aug;27(8):619-22. doi: 10.1136/jcp.27.8.619.
3
Long-term low-dosage co-trimoxazole in the management of urinary tract infection in children.长期小剂量复方磺胺甲恶唑治疗儿童尿路感染
J Antimicrob Chemother. 1976 Sep;2(3):287-91. doi: 10.1093/jac/2.3.287.
4
The use of co-trimoxazole in sulphonamide-resistant Escherichia coli urinary tract infection.复方新诺明在耐磺胺类药物的大肠杆菌尿路感染中的应用。
J Antimicrob Chemother. 1975 Sep;1(3):305-10. doi: 10.1093/jac/1.3.305.
5
Trimethoprim and co-trimoxazole in the treatment of acute urinary tract infections: patient compliance and efficacy.甲氧苄啶和复方新诺明治疗急性尿路感染：患者依从性和疗效
J R Coll Gen Pract. 1981 May;31(226):274-8.
6
Treatment of urinary tract infections in Hong Kong: a comparative study of norfloxacin and co-trimoxazole.香港地区尿路感染的治疗：诺氟沙星与复方新诺明的对比研究
Scand J Infect Dis Suppl. 1988;56:22-7.
7
Co-trimoxazole and trimethoprim in complicated urinary tract infection.复方新诺明与甲氧苄啶治疗复杂性尿路感染
Urology. 1983 Jun;21(6):645-7. doi: 10.1016/0090-4295(83)90216-9.
8
Treatment of urinary tract infection with a single dose of amoxycillin, co-trimoxazole, or trimethoprim.用单剂量阿莫西林、复方新诺明或甲氧苄啶治疗尿路感染。
Br Med J (Clin Res Ed). 1981 Nov 14;283(6302):1301-2. doi: 10.1136/bmj.283.6302.1301.
9
10
Resistance to co-trimoxazole.对复方新诺明的耐药性。
Scand J Infect Dis Suppl. 1976(8):29-38.
引用本文的文献
1
Increasing importance of plasmid-mediated trimethoprim resistance in enterobacteria: two six-month clinical surveys.质粒介导的甲氧苄啶耐药性在肠杆菌中日益重要：两项为期六个月的临床调查
Br Med J. 1980 Feb 23;280(6213):517-9. doi: 10.1136/bmj.280.6213.517.
2
3
Isolation of trimethoprim-resistant, sulfonamide-susceptible Enterobacteriaceae from urinary tract infections.从尿路感染中分离出耐甲氧苄啶、对磺胺类药物敏感的肠杆菌科细菌。
Antimicrob Agents Chemother. 1983 Apr;23(4):617-8. doi: 10.1128/AAC.23.4.617.
4
Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.复方新诺明（甲氧苄啶-磺胺甲恶唑）：抗菌活性及临床疗效的最新综述
Drugs. 1982 Dec;24(6):459-518. doi: 10.2165/00003495-198224060-00002.
5
Occurrence of transposable trimethoprim resistance in clinical isolates of Escherichia coli devoid of self-transmissible resistance plasmids.在缺乏自我传递耐药质粒的大肠杆菌临床分离株中出现可转移的甲氧苄啶耐药性。
Antimicrob Agents Chemother. 1982 Feb;21(2):336-8. doi: 10.1128/AAC.21.2.336.
6
Emergence of trimethoprim resistance in fecal flora.粪便菌群中出现甲氧苄啶耐药性。
Antimicrob Agents Chemother. 1985 Aug;28(2):354-6. doi: 10.1128/AAC.28.2.354.
7
Unusual expression of new low-level-trimethoprim-resistance plasmids.新型低水平甲氧苄啶耐药质粒的异常表达。
J Clin Microbiol. 1986 Jul;24(1):61-4. doi: 10.1128/jcm.24.1.61-64.1986.
Zotero 插件